Perritt Capital Management Inc Bristol Myers Squibb CO Transaction History

Perritt Capital Management Inc

$193 Million
Q3 2025

A detailed history of Perritt Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Perritt Capital Management Inc holds 8,575 shares of BMY stock, worth $401,395. This represents 0.2% of its overall portfolio holdings.

Number of Shares

8,575

Previous 8,432 1.7%

Holding current value

$401,395

Previous $390,000 1.03%

% of portfolio

0.2%

Previous 0.22%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$43.31 - $48.98 $6,193 - $7,004	143 Added 1.7%	8,575 $386,000
Q2 2025 Aug 14, 2025	SELL	$44.12 - $59.6 $16.9 Million - $22.8 Million	-381,921 Reduced 97.84%	8,432 $390,000
Q2 2025 Aug 12, 2025	BUY	$44.12 - $59.6 $16.8 Million - $22.8 Million	381,721 Added 4422.16%	390,353 $18.1 Million
Q1 2025 May 13, 2025	SELL	$53.9 - $63.11 $44,467 - $52,065	-825 Reduced 8.72%	8,632 $526,000
Q4 2024 Feb 12, 2025	BUY	$51.92 - $59.94 $62,823 - $72,527	1,210 Added 14.67%	9,457 $534,000

Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $23,201 - $30,273	-585 Reduced 6.62%	8,247 $426,000
Q2 2024 Aug 07, 2024	BUY	$40.25 - $52.99 $51,721 - $68,092	1,285 Added 17.03%	8,832 $366,000
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $13,578 - $15,395	283 Added 3.9%	7,547 $409,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $76,452 - $91,229	-1,577 Reduced 17.84%	7,264 $372,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $101,936 - $113,183	1,600 Added 22.1%	8,841 $565,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $3,942 - $4,471	60 Added 0.84%	7,241 $501,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $6,916 - $8,190	101 Added 1.43%	7,181 $516,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $16 - $9,605	125 Added 1.8%	7,080 $503,000
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $58,406 - $70,034	950 Added 15.82%	6,955 $508,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $536 - $625	10 Added 0.17%	6,005 $374,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $24,259 - $28,417	410 Added 7.34%	5,995 $355,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $69,029 - $75,173	1,115 Added 24.94%	5,585 $373,000
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $265,249 - $298,327	4,470 New	4,470 $282,000
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $164,321 - $213,085	-3,370 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $185,990 - $209,782	3,370 New	3,370 $209,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $293,074 - $365,284	-5,800 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $5,992 - $6,898	-100 Reduced 1.69%	5,800 $301,000
Q4 2017 Jan 25, 2018	BUY	$59.94 - $65.35 $7,192 - $7,841	120 Added 2.08%	5,900 $362,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $319,229 - $368,417	5,780	5,780 $368,000

Others Institutions Holding BMY

# of Institutions

2,682

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.

Account

Perritt Capital Management Inc Bristol Myers Squibb CO Transaction History